Skip to content
★ Sign in to follow
DS
Total declarations
18
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (8 ops.)
€130k

Latest filing published 02 May 2017 for Abbott Laboratories, €7,594.

Filing timeline

BuySale
Deepak S. Nath

Insider track record

Disclosed buys
0
Disclosed sells
8
Signal history

Deepak S. Nath: trading record in brief

This profile gathers the share dealings of Deepak S. Nath in Abbott Laboratories. In total, 18 filings cover trades dated from 28 April 2015 to 28 April 2017.

The open-market record consists of 8 sales worth €130k, with no purchase. The rest of the record consists of 10 share grants. In 2017 alone, the filings show no purchases and 2 sales.

Most recently, on 2 May 2017, the filings show a share grant worth €7,594 in Abbott Laboratories. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Deepak S. Nath

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    8,250 USD11SEC
    189 shares@ US$43.651.6% of flowCommon shares without par valueSEC:0001179110-17-006400:0
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    195,569 USD15SEC
    4,302 shares@ US$45.4638.5% of flowCommon shares without par valueSEC:0001179110-17-003681:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    72,669 USD30SEC
    1,601 shares@ US$45.3914.3% of flowCommon shares without par valueSEC:0001179110-17-003681:1
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    36,601 USD12SEC
    819 shares@ US$44.697.2% of flowCommon shares without par valueSEC:0001179110-17-002931:1
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    14,349 USD29SEC
    319 shares@ US$44.982.8% of flowCommon shares without par valueSEC:0001179110-17-002931:2
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    0SEC
    11,089 shares0Common shares without par valueSEC:0001179110-17-002931:0
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    5,961 USD11SEC
    136 shares@ US$43.831.1% of flowCommon shares without par valueSEC:0001179110-16-023446:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    2,189 USD23SEC
    53 shares@ US$41.310.4% of flowCommon shares without par valueSEC:0001179110-16-023446:1
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    80,621 USD13SEC
    2,040 shares@ US$39.5215.4% of flowCommon shares without par valueSEC:0001179110-16-020739:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    27,214 USD30SEC
    693 shares@ US$39.275.2% of flowCommon shares without par valueSEC:0001179110-16-020739:1
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    3,928 USD29SEC
    100 shares@ US$39.280.7% of flowCommon shares without par valueSEC:0001179110-16-020739:2
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    0SEC
    16,601 shares0Common shares without par valueSEC:0001179110-16-019895:0
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    31,556 USD12SEC
    819 shares@ US$38.535.9% of flowCommon shares without par valueSEC:0001179110-16-019895:1
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    743 USD29SEC
    19 shares@ US$39.090.1% of flowCommon shares without par valueSEC:0001179110-16-019895:2
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    11,730 USD29SEC
    300 shares@ US$39.102.2% of flowCommon shares without par valueSEC:0001179110-16-019895:3
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    18,602 USD11SEC
    501 shares@ US$37.133.4% of flowCommon shares without par valueSEC:0001179110-16-019503:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    6,349 USD29SEC
    171 shares@ US$37.131.2% of flowCommon shares without par valueSEC:0001179110-16-019503:1
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    6,839 USD0SEC
    144 shares@ US$47.49Common shares without par valueSEC:0001179110-15-006829:0

18 of 18 declarations